Clinical trial
Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
NCT00790868 is registered in ClinicalTrials.gov with Boston University Charles River Campus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder
- Lead sponsor
- Boston University Charles River Campus
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2008
- Completion date
- August 31, 2014
- Enrollment
- 180 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.